State of the Industry Symposium

Size: px
Start display at page:

Download "State of the Industry Symposium"

Transcription

1 State of the Industry Symposium Speaker: Lindsay Forrest, Chair, Australian Self Medication Industry (ASMI) Association Proudly sponsored by:

2 Voice of the Consumer Healthcare Products Industry Peak industry body representing: Sponsors of non-prescription medicines Non-prescription = Over-the-Counter (OTC) & Complementary Medicines (CM) ASMI members make up approx. 80% of the $5bn+ non-prescription market

3 Today 1. State of Consumer Healthcare Industry 2. Schedule 3 Consumer Advertising 3. Front of shop growth opportunities for Pharmacy Proudly sponsored by:

4 State of Consumer Healthcare Industry Proudly sponsored by:

5 Value Growth (%) Overall pharma market grew over 20% due to Rx Hepatitis C listings altering Rx/OTC share of market % 5.1% 0.2% 2013 Proudly sponsored by: Growth of the OTC market vs. total Pharma market 23.6% Source: QuintilesIMS National Audits (API+AHI) ex-wholesaler list price MAT December 27.7% 28.2% 26.2% 20.1% 10.8% 11.5% 6.6% 1.6% OTC Share of market OTC Total market

6 All OTC categories still driving strong growth front of shop for pharmacy 770 (17.2%) Sales (A$ million) and Market Share 651 (14.5%) 434 (9.7%) 318 (7.1%) 306 (6.8%) *Includes Multivitamins Adult, Multivitamins Child and VMS Other **Excludes Acne and Antifungal treatments ***Excludes Asthma and anti-allergics, expectorants and cough relievers Source: QuintilesIMS National Audits (API+AHI) ex-wholesaler list price MAT December 2016 Proudly sponsored by: 235 (5.2%) 163 (3.6%) ANTI DIARRHOEALS 142 (3.2%) OTHER RESPIRATORY*** 119 (2.7%) SMOKING CESSATION 111 (2.5%) INFANT FORMULAS MULTIVITAMINS* OTHER SKIN TREATMENT** ASTHMA & ANTI-ALLERGICS PAIN RELIEF - GEN SYSTEMIC LAXATIVES CALCIUM SUPPLEMENTS -5.0% Growth (%) 6.5% 6.7% 11.2% 7.7% 8.4% 13.6% 10.9% 45.3% +13% Growth 84.0% +28% Growth

7 Schedule 3 Advertising Proudly sponsored by:

8 PROPOSED S3 ADVERTISING MODEL Pharmacy & Consumer Communication Preparing Pharmacy Implementation of clinical protocols and product information to all pharmacists prior to commencement of advertising Consumer Communications New S3 communication model incorporated into all forms of consumer communication* Importance of Pharmacist role Condition Branded Awareness Product Informatio n

9 PROPOSED S3 ADVERTISING MODEL Pharmacy & Consumer Communication Preparing Pharmacy Implementation of clinical protocols and product information to all pharmacists prior to commencement of advertising Consumer Communications New S3 communication model incorporated into all forms of consumer communication* Importance of Pharmacist role Condition Branded Awareness Product Informatio n

10 PROPOSED S3 ADVERTISING MODEL Pharmacy & Consumer Communication Preparing Pharmacy Implementation of clinical protocols and product information to all pharmacists prior to commencement of advertising Consumer Communications New S3 communication model incorporated into all forms of consumer communication* Importance of Pharmacist role Condition Branded Awareness Product Informatio n *Exception List non advertised when not in public interest

11 PROPOSED S3 ADVERTISING MODEL Mock Ad Demonstrating Model in Practice com/watch?v=1yhzdp 0_rWQ Cut to VIDEO

12 Top Line ESTIMATING THE QUM IMPACT OF SCHEDULE 3 CONSUMER ADVERTISING Results UTS CHERE RESEARCH TEAM: PROF STEPHENGOODALL, PROF ROSALIE VINEY, DR FEI-LI ZHAO, PROF DEBORAH STREET UTS CRICOS PROVIDER CODE: 00099F Research Sample Size: 1,295 Consumers (50% sufferer & 50% non-sufferers) 501 Pharmacists 500 Pharmacy Assistants chere.uts.edu.au

13 Consumer Results

14 Advertising DOES influence Consumer health-seeking behaviour RESEARCH INSIGHT - After seeing the advert, consumers more likely to visit pharmacy for cold sore (minor ailment) than GP Ask your Pharmacist well received by consumers Advertising created awareness of pharmacy services for this condition OUTCOME: Better use of Healthcare Resources for minor ailments

15 Advertising drives POSITIVE Consumer-Pharmacist engagement RESEARCH INSIGHT After advertising, Pharmacist Recommendation had positive & significant impact on consumer choice The ad made me more likely to visit a pharmacy for health advice in the future for other minor health conditions 57% Consumers AGREE I will let the pharmacist determine whether Brand FAM is an appropriate treatment for me Only 8% Consumers DISAGREED OUTCOMES 1. Advertising drives More Health Conversations between consumers and pharmacists 2. Advertising Unlikely to drive inappropriate demand for advertised brand

16 S3 Advertising model RECALIBRATES consumer expectations Pharmacist recommendation MORE IMPORTANT to consumers WITH advertising Consumer Driver to buy

17 Pharmacist Results

18 S3 Advertising does NOT influence choices made by Pharmacists Pharmacist - WTP_Pharmacist_cLogit Drivers to Recommend Customer direct request : No request Customer anti-viral appropriate : inappropriate Control Advertisement No significant difference between test & control 3rd most effective : Least effective 2nd most effective : Least effective Most effective : Least effective Less frequent use : More freqeutne use Pharmacist only (S3) : Front of Pharmacy Pharmacy-brand antiviral cream : Lip balm Branded antiviral cream : Lip balm Pharmacist-brand antiviral tablet : Lip balm Brand FAM : Lip balm

19 S3 Advertising does NOT influence choices made by Pharmacists Pharmacist - WTP_Pharmacist_cLogit Drivers to Recommend Customer direct request : No request Customer anti-viral appropriate : inappropriate Control Advertisement 3rd most effective : Least effective 2nd most effective : Least effective Most effective : Least effective Less frequent use : More freqeutne use Pharmacist only (S3) : Front of Pharmacy Pharmacy-brand antiviral cream : Lip balm Branded antiviral cream : Lip balm Pharmacist-brand antiviral tablet : Lip balm ONLY SIGNIFICANT DRIVER TO RECOMMENDATION - Whether therapy appropriate Brand FAM : Lip balm

20 S3 Advertising does NOT influence choices made by Pharmacists INSIGHT Vast Majority of Pharmacists comfortable referring up or denying consumer request if medicine not appropriate I am comfortable to deny a customer s direct request for a specific medicine if I consider this medicine is inappropriate for the customer Only 14% of Pharmacists DISAGREED I am comfortable referring customers to their GP if necessary Only 9.6% of Pharmacists DISAGREED OUTCOME: Pharmacists appropriately triage consumers & better suited course of action recommended

21 QUALITY USE OF MEDICINES CONCERNS ADDRESSED MYTH WHAT THE EVIDENCE SAYS

22 QUALITY USE OF MEDICINES CONCERNS ADDRESSED MYTH Medicine advertising just sells the brand advertised WHAT THE EVIDENCE SAYS S3 Advertising increases consumer awareness of: Therapeutic options available Pharmacy Services S3 Advertising drives more health conversations between pharmacists and consumers

23 QUALITY USE OF MEDICINES CONCERNS ADDRESSED MYTH Medicine advertising just sells the brand advertised Medicine advertising drives inappropriate demand WHAT THE EVIDENCE SAYS S3 Advertising increases consumer awareness of: Therapeutic options available Pharmacy Services S3 Advertising drives more health conversations between pharmacists and consumers Consumer comfortable with Pharmacists determining whether advertised S3 product is right for them

24 QUALITY USE OF MEDICINES CONCERNS ADDRESSED MYTH Medicine advertising just sells the brand advertised Medicine advertising drives inappropriate demand Pharmacists buckle under pressure of consumer demand generated by advertising WHAT THE EVIDENCE SAYS S3 Advertising increases consumer awareness of: Therapeutic options available Pharmacy Services S3 Advertising drives more health conversations between pharmacists and consumers Consumer comfortable with Pharmacists determining whether advertised S3 product is right for them Pharmacists appropriately triage consumers and better suited course of action recommended if advertised product not appropriate (referral to GP or alternate product)

25 Benefits of Proposed S3 Advertising Model

26 Benefits of Proposed S3 Advertising Model

27 Benefits of Proposed S3 Advertising Model

28 Benefits of Proposed S3 Advertising Model BETTER QUM OUTCOMES WITH S3 ADVERTISING MODEL!

29 Front of Shop Growth Opportunities 1. Reigniting S3 category 2. Rx to OTC switch (only once S3 advertising fixed!) 3. Minor ailment management/pharmacy services expansion 4. Pharmacists & Complementary meds helping consumers separate wheat from chaff Evidence-based Complementary therapies Informing consumer choice 5. Off-Shore demand for Australian consumer healthcare products broadening Continues to spread across more OTC categories Evolving off shore regulations Proudly sponsored by:

30 Proudly sponsored by: Thank You

Estimating the impact of schedule 3 consumer advertising

Estimating the impact of schedule 3 consumer advertising Estimating the impact of schedule 3 consumer advertising Final Report November 2016 A report by the Centre for Health Economics Research and Evaluation About CHERE CHERE is an independent research unit

More information

Media That Delivers Media Kit

Media That Delivers Media Kit Media That Delivers For more than 15 years, Rx EDGE has been leading the way in redefining the media landscape with pharmaceutical marketing programs delivered through a network of nearly 30,000 retail

More information

Herbals & Naturals. Opportunities in a Vast & Dynamic Area of Consumer Health

Herbals & Naturals. Opportunities in a Vast & Dynamic Area of Consumer Health CELEBRATING Herbals & Naturals Opportunities in a Vast & Dynamic Area of Consumer Health Herbals & Naturals are driving growth across multiple markets and categories Key Features 9 core markets demonstrating

More information

Exploring Opportunities for Growth in Sleep Aids & Sedatives CELEBRATING 40 YEARS OF CONSUMER HEALTHCARE

Exploring Opportunities for Growth in Sleep Aids & Sedatives CELEBRATING 40 YEARS OF CONSUMER HEALTHCARE Sleep Exploring Opportunities for Growth in Sleep Aids & Sedatives Sleep Exploring Opportunities for Growth in Sleep Aids & Sedatives Sleep is a sizeable well-established consumer health category worth

More information

Rx EDGE. Patient Aquisition and Patient Adherence Programs. Contents. Pharmacy Networks

Rx EDGE. Patient Aquisition and Patient Adherence Programs. Contents. Pharmacy Networks Rx EDGE Pharmacy Networks Patient Aquisition and Patient Adherence Programs Whether your goal is to build brand awareness or to reinforce your message with patients on therapy, Rx EDGE Pharmacy Networks

More information

FRANCHE COMMUNITY PRIMARY SCHOOL & Policies & Procedures

FRANCHE COMMUNITY PRIMARY SCHOOL & Policies & Procedures Title: Storage and Administering of Medicines Method Statement & Policy 2018-19 DOCUMENT MANAGEMENT This document was adopted at the PAW Committee Meeting on 24 th January 2018 This document is subject

More information

Cough & Sore Throat Insights & Strategies for Cough & Sore Throat Remedies

Cough & Sore Throat Insights & Strategies for Cough & Sore Throat Remedies Cough & Sore Throat Insights & Strategies for Cough & Sore Throat Remedies Key features of the report An in-depth exploration of Cough remedies and Sore Throat remedies & Medicated confectionery Landscaping

More information

The Future of OTC in Asia: Growth through Innovation Andy Tisman, Senior Principal Consumer Health IMS Health

The Future of OTC in Asia: Growth through Innovation Andy Tisman, Senior Principal Consumer Health IMS Health WSMI AP Regional Conference & APSMI General Assembly The Future of OTC in Asia: Growth through Innovation Andy Tisman, Senior Principal Consumer Health IMS Health OTC continues to show healthy growth,

More information

WORKPLACE ASSESSMENTS STUDENT INFORMATION SIR30116 Certificate III in Community Pharmacy

WORKPLACE ASSESSMENTS STUDENT INFORMATION SIR30116 Certificate III in Community Pharmacy WORKPLACE ASSESSMENTS STUDENT INFORMATION SIR30116 Certificate III in Community Pharmacy As you are aware you are enrolled in the above qualification through your position with the My Chemist Warehouse

More information

Moving from volume to value in the generic business model

Moving from volume to value in the generic business model Moving from volume to value in the generic business model CPhI Pre-connect conference Frankfurt 23rd October 2017 Copyright 2016 QuintilesIMS. All rights reserved. Key drivers to 2021 Global growth moderating

More information

Policy principles for a competitive healthcare environment

Policy principles for a competitive healthcare environment Policy principles for a competitive healthcare environment Pharmaceutical Research and Development Industry Malta Association (PRIMA) PRIMA is an affiliate of the European Federation of Pharmaceutical

More information

INFLUENCE PHARMACY RETAIL

INFLUENCE PHARMACY RETAIL COMBINING PHARMACY S PROFESSIONAL EXCELLENCE WITH BUSINESS ACUMEN THE OPPORTUNITY TO INFLUENCE PHARMACY RETAIL MEDIA INFORMATION 2015 Helping healthcare professionals become commercially savvy While the

More information

Path to Purchase: Over the Counter

Path to Purchase: Over the Counter Path to Purchase: Over the Counter CONDUCTED BY ON BEHALF OF The Purpose. Understanding recent developments, showcasing consumer behaviour digital-wise in general and search-wise in particular in the OTC

More information

The future of pharmacy is multichannel, with a fast growing digital focus.

The future of pharmacy is multichannel, with a fast growing digital focus. PRESS RELEASE May 2014 SEMPORA market study: The UK retail pharmacy market 2014: consumer survey The future of pharmacy is multichannel, with a fast growing digital focus. London, 21 st May 2014 The latest

More information

A Study on Consumer Behavior for OTC Medicine Segment

A Study on Consumer Behavior for OTC Medicine Segment Continuous Issue - 20 June July 2017 Abstract A Study on Consumer Behavior for OTC Medicine Segment The current research is aimed at to understand the consumer s attitude towards OTC products of the pharmaceutical

More information

June 4, Jefferies Global Healthcare Conference

June 4, Jefferies Global Healthcare Conference June 4, 2015 Jefferies Global Healthcare Conference Safe Harbor Statement The following presentation includes forward-looking statements within the meaning of the safe harbor provisions of the Private

More information

Current Trends in the Biomedical Industry Series. Session 10 Marketing Practices for Product Launch October 31, 2007

Current Trends in the Biomedical Industry Series. Session 10 Marketing Practices for Product Launch October 31, 2007 Current Trends in the Biomedical Industry Series Session 10 Marketing Practices for Product Launch October 31, 2007 Agenda: Marketing Practices at Launch Success Drivers The Physician Dynamic Role of Time

More information

Shoppers know best. Balázs Kertész Director of Research & Innovation. April 2015

Shoppers know best. Balázs Kertész Director of Research & Innovation. April 2015 A member of group Shoppers know best Balázs Kertész Director of Research & Innovation April 2015 Part 1. Why Go Mystery Shopping? Part 2. Case Study: Mystery Patient Research Part 3. Case Study: Measuring

More information

Rx EDGE. Best Practices. Solutions at the Shelf programs from Rx EDGE. Pharmacy Networks. White Paper

Rx EDGE. Best Practices. Solutions at the Shelf programs from Rx EDGE. Pharmacy Networks. White Paper Rx EDGE Best Practices Solutions at the Shelf programs from Rx EDGE White Paper Get the most from your Rx EDGE Solutions at the Shelf program Quantifiable, measurable, actionable these are words not often

More information

OTC, Self-Care Medical Devices, Food Supplements and Herbal Products: Market trends and Opportunities in Germany and Central Europe

OTC, Self-Care Medical Devices, Food Supplements and Herbal Products: Market trends and Opportunities in Germany and Central Europe OTC, Self-Care Medical Devices, Food Supplements and Herbal Products: Market trends and Opportunities in Germany and Central Europe Dr. Frank Wartenberg President Central Europe, GM Germany Copyright 2017

More information

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication

MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication MEDICATION GUIDE RIBAVIRIN TABLETS Rx Only Read this Medication Guide carefully before you start taking ribavirin tablets and read the Medication Guide each time you get more ribavirin tablets. There may

More information

GSK Consumer Health Supplier Relationship Team (SRT) Concept. Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS

GSK Consumer Health Supplier Relationship Team (SRT) Concept. Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS GSK Consumer Health Supplier Relationship Team (SRT) Concept Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS Introduction to GSK Consumer Health Link between Supply Chain and Supplier Relationship

More information

Increasing Access to Nonprescription Medicines: A Global Public Health Challenge and Opportunity Edwin Hemwall, PhD

Increasing Access to Nonprescription Medicines: A Global Public Health Challenge and Opportunity Edwin Hemwall, PhD Edwin Hemwall, PhD Session Overview The case for public health benefit from Rx-to-OTC Switch and the role in modern healthcare settings The global switch environment today Opportunities and Challenges

More information

Moberg Pharma AB A DIFFERENT KIND OF PHARMA COMPANY

Moberg Pharma AB A DIFFERENT KIND OF PHARMA COMPANY Moberg Pharma AB A DIFFERENT KIND OF PHARMA COMPANY Corporate Presentation Remium Health Care Capital Market Day Dec 2, 2013 Peter Wolpert, CEO and Founder Disclaimer Statements included herein that are

More information

2/10/ B: The Essentials. Statement of Conflict of Interest. CE Question

2/10/ B: The Essentials. Statement of Conflict of Interest. CE Question 10 th Annual 340B Coalition Winter Conference Pre-Conference Workshop-Part 2 340B: The Essentials Rebecca Cheek, PharmD, BCACP, CACP Director of Pharmacy White House Clinics February 5, 2014 Statement

More information

Rx EDGE. Retail strategy considerations for the launch of a new product or indication. White Paper. Pharmacy Networks

Rx EDGE. Retail strategy considerations for the launch of a new product or indication. White Paper. Pharmacy Networks Retail strategy considerations for the launch of a new product or indication White Paper Introduction One of the most difficult and stressful marketing decisions in pharmaceutical new product launches

More information

Wendy Poirier, Director of Towers Watsons Canadian Health & Group Benefits Practice talks about the Canadian Rx Coalition

Wendy Poirier, Director of Towers Watsons Canadian Health & Group Benefits Practice talks about the Canadian Rx Coalition EXCLUSIVE INTERVIEW: Wendy Poirier, Director of Towers Watsons Canadian Health & Group Benefits Practice talks about the Canadian Rx Coalition Today I am pleased to interview Wendy Poirier Director of

More information

Introduction of OTC switch in China. Han Qing Regulatory Affairs of One China OTC J&J Oct

Introduction of OTC switch in China. Han Qing Regulatory Affairs of One China OTC J&J Oct Introduction of OTC switch in China Han Qing Regulatory Affairs of One China OTC J&J Oct 22 2014 Outline Regulatory History Classification Switch Challenges Regulatory History 3 stages Stage 1: before

More information

2009 National Pharmacy Study SM

2009 National Pharmacy Study SM Mass Merchandiser Performance September 2009 Healthcare Practice Table of Contents Topic Page # Overview of Findings... MM-3 Overall Customer Satisfaction...MM-5 Non-Pharmacist Staff MM-8 Store Convenience

More information

Pharmaceutical market

Pharmaceutical market 3/14/218 Pharmaceutical market Hynek Valerián Copyright 218 IQVIA. All rights reserved. Table of Contents + Global pharmaceutical market Regions and growth contribution Biologic products + Czech Republic

More information

medotceurope.com Winter/Spring 2005 Inside medotceurope.com

medotceurope.com Winter/Spring 2005 Inside medotceurope.com Leaders Time to Think Change in OTC Distribution in Europe A Brief look at Self-medication in Hungary Inside Launch of Medotceurope.com online database medotceurope.com Winter/Spring 2005 Time to think

More information

Guidelines for Social Media Engagement. for the Consumer Health Product Industry VOLUNTARY GUIDE

Guidelines for Social Media Engagement. for the Consumer Health Product Industry VOLUNTARY GUIDE Guidelines for Social Media Engagement for the Consumer Health Product Industry VOLUNTARY GUIDE March 2016 Table of Contents 1.0 Background. 3 1.1 Objective.. 3 1.2 Guiding Principles.. 4 2.0 Scope.. 4

More information

You are in good hands.

You are in good hands. You are in good hands. Health and Medical Technology Exhibition 11 13 October 2018 exhibition you have a program PROFESSIONAL EXHIBITION ORGANIZER For 50 years, Hungexpo has been the leader in Hungary

More information

The need for generic policies as part of health reform

The need for generic policies as part of health reform The need for generic policies as part of health reform Richard Laing EMP/WHO for PPRI Conference Vienna September 30 th 2011 The US Generics Market reaches $107.5bn with growth four times higher than total

More information

Drug Spending % of Healthcare Spending DRUG SPENDING % OF HEALTHCARE SPENDING 20% 15% 10% 5% 0% 1995 2000 2005 2010 2015 Japan, 15.0% France, 9.8% US Net, 9.8% UK, 9.7% Germany, 9.0% France Germany Japan

More information

Drugs and Medical Devices Regulatory & Industry Overview

Drugs and Medical Devices Regulatory & Industry Overview Drugs and Medical Devices Regulatory & Industry Overview Presented to: Vanderbilt University April 10, 2013 Charles N. (Chuck) Jolly cjolly@bakerdonelson.com Ph. 410.648.5004 or 914-924-0738 (cell) Industry

More information

RECALLS: THE CONSUMER PERSPECTIVE

RECALLS: THE CONSUMER PERSPECTIVE RECALLS: THE CONSUMER PERSPECTIVE Mark Vare Sr. Director Recall Solution / Inmar Agenda An Exploration of: 1. Consumer study results 2. Terminology 3. Experience with product category 4. Expectations for

More information

Tucked away in a building A GROWING COMPANY DEEPLY ROOTED IN THE HUDSON VALLEY COMPANY PROFILE ULTRA SEAL CORP. AND ULTRA TAB LABORATORIES

Tucked away in a building A GROWING COMPANY DEEPLY ROOTED IN THE HUDSON VALLEY COMPANY PROFILE ULTRA SEAL CORP. AND ULTRA TAB LABORATORIES COMPANY PROFILE ULTRA SEAL CORP. AND ULTRA TAB LABORATORIES A GROWING COMPANY DEEPLY ROOTED IN THE HUDSON VALLEY Tucked away in a building right off the New York State Thruway on Route 299 in New Paltz,

More information

Best Practices for Program Success. Solutions at the Shelf from Rx EDGE. Rx EDGE. Pharmacy Networks. Media That Delivers

Best Practices for Program Success. Solutions at the Shelf from Rx EDGE. Rx EDGE. Pharmacy Networks. Media That Delivers Best Practices for Program Success Solutions at the Shelf from Rx EDGE Rx EDGE Pharmacy Networks Media That Delivers White Paper - 2017 Welcome! This is your Solutions at the Shelf best practices road

More information

Innovative Approaches to Saving Patients Money on Prescription Drug Costs

Innovative Approaches to Saving Patients Money on Prescription Drug Costs Innovative Approaches to Saving Patients Money on Prescription Drug Costs April 2018 1 Innovative Approaches to Saving Patients Money on Prescription Drug Costs Executive Summary As prescription drug prices

More information

Compounding Pearls Member Panel

Compounding Pearls Member Panel Compounding Pearls Member Panel Kate James, RPh Cliff Holt, RPh Bobby Muniz, PharmD International Seminar Houston, TX November 10 12, 2016 2016. All Rights Reserved. 1 Pharmacist Follow up Program The

More information

D&E DATOS Y ESTRATEGIAS PHYSICIANS PERCEPTIONS ABOUT THE PROMOTIONAL PRESSURE BY NATIONAL AND MULTINATIONAL PHARMACEUTICAL COMPANIES

D&E DATOS Y ESTRATEGIAS PHYSICIANS PERCEPTIONS ABOUT THE PROMOTIONAL PRESSURE BY NATIONAL AND MULTINATIONAL PHARMACEUTICAL COMPANIES PHYSICIANS PERCEPTIONS ABOUT THE PROMOTIONAL PRESSURE BY NATIONAL AND MULTINATIONAL PHARMACEUTICAL COMPANIES FOR THE PERIOD 2005-2013 Survey 2013 1 CURRENT SCENARIO IN ARGENTINA The pharmaceutical industry

More information

Rodale s DTC th YEAR DTC STUDY

Rodale s DTC th YEAR DTC STUDY Rodale s DTC 12 th YEAR DTC Landscape DTC spending decreased 18% in 2008 DTC ad expenditures expected to decline in No ED ads until 10pm The Recession More powerful Henry Waxman Do DTC ads work? Prescription

More information

UBCM Conference. Joanne Jung, BScPharm Director, Pharmacy Services Mar 10, 2016

UBCM Conference. Joanne Jung, BScPharm Director, Pharmacy Services Mar 10, 2016 UBCM Conference Joanne Jung, BScPharm Director, Pharmacy Services Mar 10, 2016 Agenda Drug Landscape Private drug plan trends Cost drivers Specialty Drugs Drug Trends Top Therapeutic Classes Drug Plan

More information

smarter solutions better adherence improved results

smarter solutions better adherence improved results smarter solutions better adherence improved results Medication non-adherence is a big problem Costs the healthcare system roughly $300 billion Prescription Adherence Rates Significant drop in adherence

More information

Understanding The World Of Specialty. And Why We Should Care?

Understanding The World Of Specialty. And Why We Should Care? Understanding The World Of Specialty Drugs And Why We Should Care? What Are Specialty Drugs? Specialty Drugs are drugs used for the treatment of complex conditions and they often require special storage,

More information

Adams Conference Call to Discuss Acquisition of Delsym 12-Hour Cough Suppressant Liquids From UCB May 25, 2006

Adams Conference Call to Discuss Acquisition of Delsym 12-Hour Cough Suppressant Liquids From UCB May 25, 2006 Adams Conference Call to Discuss Acquisition of Delsym 12-Hour Cough Suppressant Liquids From UCB May 25, 2006 Safe Harbor This presentation contains certain forward-looking statements. These statements

More information

Building Brand Equity: The Mucinex Story

Building Brand Equity: The Mucinex Story Building Brand Equity: The Mucinex Story Bob Casale June 4, 2009 Small Company Growth Compound Annual Growth Rate From 2003 2008: 102% $468 $160 $239 $331 REVENUE IN MILLIONS $61 $14 2003 2004 2005 2006

More information

IT S WHAT YOU CAN T SEE THAT HURTS YOU IS THE PHARMACEUTICAL INDUSTRY REPLACING EXISTING MEDICATIONS WITH MORE EXPENSIVE MEDICATIONS?

IT S WHAT YOU CAN T SEE THAT HURTS YOU IS THE PHARMACEUTICAL INDUSTRY REPLACING EXISTING MEDICATIONS WITH MORE EXPENSIVE MEDICATIONS? SPECIALTY DRUGS Many plan sponsors have had to make difficult and painful choices about how to spend pharmacy benefit dollars But now payors are once again challenged not just by extremely high costs but

More information

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Dave Bode VP, Health Care Solutions DSC Logistics April 20, 2016 Health

More information

Upper GIs. Investigating the Self-Care Market for Upper Gastrointestinals. Main features of the report

Upper GIs. Investigating the Self-Care Market for Upper Gastrointestinals. Main features of the report Upper GIs Investigating the Self-Care Market for Upper Gastrointestinals Main features of the report An in-depth exploration of the Upper GIs market, including Antacids, Antiflatulents, Antinauseants,

More information

Better Access, Better Health A guide to the generic and biosimilars medicines market and pricing

Better Access, Better Health A guide to the generic and biosimilars medicines market and pricing Better Access, Better Health A guide to the generic and biosimilars medicines market and pricing Section 1: About the BGMA & Generics The British Generic Manufacturers Association (BGMA) is made up of

More information

Submission to the Department of Health (Fed) regarding. Biosimilar Uptake Drivers Implementation. This joint submission is made by:

Submission to the Department of Health (Fed) regarding. Biosimilar Uptake Drivers Implementation. This joint submission is made by: Submission to the Department of Health (Fed) regarding Biosimilar Uptake Drivers Implementation This joint submission is made by: The Society of Hospital Pharmacists of Australia (SHPA) SHPA is the national

More information

Drivers for Continuous Tablet Manufacturing in Pharmaceutical Industry

Drivers for Continuous Tablet Manufacturing in Pharmaceutical Industry Drivers for Continuous Tablet Manufacturing in Pharmaceutical Industry Satu Lakio PhD (pharm.), Adj. Prof. Industrialisation and product life cycle management Orion Pharma 29th Annual Symposium of the

More information

*Brevity is the Soul of Wit.

*Brevity is the Soul of Wit. Over the counter Medication, the FDA and Health Information Exchanges : Why is it important? James M. Tracy, D.O., FAAAAI, FACAAI, FAAP Creighton University Division of Allergy and Immunology Omaha, Nebraska

More information

Pharmamarketing - strategic challenges

Pharmamarketing - strategic challenges Pharmamarketing - strategic challenges Biomedicine Master Program Lund University Course: Biomedicine the Profession Anna Chérouvrier Hansson, MSc. December 16th, 2014 1. Pharmamarketing - definitions

More information

Are Biosimilars the Panacea for High Cost Specialty Drugs?

Are Biosimilars the Panacea for High Cost Specialty Drugs? Are Biosimilars the Panacea for High Cost Specialty Drugs? Mid-sized Retirement and Healthcare Plan Management San Francisco, CA March 27, 2018 2018. Innovative Rx Strategies, LLC. All rights reserved.

More information

Encouraging a culture of voluntary compliance Medicare Australia s compliance management approach and philosophy

Encouraging a culture of voluntary compliance Medicare Australia s compliance management approach and philosophy Encouraging a culture of voluntary compliance Medicare Australia s compliance management approach and philosophy Colin Bridge General Manager Program Review Division Outline of presentation About Medicare

More information

UPPER RESPIRATORY & PAIN RELIEF

UPPER RESPIRATORY & PAIN RELIEF UPPER RESPIRATORY & PAIN RELIEF February 2017 AGENDA U.S. Retail Hot Buttons Driving Growth The Increasing Importance of Health & Wellness Health & Wellness Drivers Category Performance Pain Relief Cough

More information

PVM Pharmacy Customer Satisfaction Structural Equations Models. Multivariate Solutions

PVM Pharmacy Customer Satisfaction Structural Equations Models. Multivariate Solutions PVM Pharmacy Customer Satisfaction Structural Equations Models Multivariate Solutions Basics of Structural Equation Models Structural equation modeling (SEM) is a statistical technique for building and

More information

A New Standard Of Providing Subjects Unblinded Medication And Supplies

A New Standard Of Providing Subjects Unblinded Medication And Supplies A New Standard Of Providing Subjects Unblinded Medication And Supplies Tom Heck May 2017 Introduction Tom Heck President RxSolutions, Inc. 24 years in Pharmaceuticals Integral or in leadership at six specialty

More information

The Medco Pharmacy delivers to you.

The Medco Pharmacy delivers to you. Sign-in/Register My Account My Favorites Order Status Help Contact Us 0 ITEMS 0.00 the Medco Pharmacy PRESCRIPTIONS & BENEFITS HEALTH RESOURCE CENTER MEDCO HEALTH STORE Recommended for you: Going to the

More information

Marketing Pack. Store Promotions & Artwork JUNE Fresh Creative:

Marketing Pack. Store Promotions & Artwork JUNE Fresh Creative: Marketing Pack Store Promotions & Artwork JUNE 2017 1 Introduction 2 Capital Chemist Marketing Material This guide provides Capital Chemist stores with a range of approved marketing material which has

More information

Put Money Back in Your Classroom Finding the hidden revenue in your pharmacy benefits

Put Money Back in Your Classroom Finding the hidden revenue in your pharmacy benefits Put Money Back in Your Classroom Finding the hidden revenue in your pharmacy benefits Presented by Howard Mazzafro, Vice President Innovative Slide 1 of 25 Solutions. Enduring Principles. Innovative Solutions.

More information

Self Care Medical Devices Advertising Guideline

Self Care Medical Devices Advertising Guideline Self Care Medical Devices Advertising Guideline 11 July 2016 FOR MORE INFORMATION OR CLARIFICATION ABOUT ADVERTISING SELF CARE MEDICAL DEVICES, PLEASE CONTACT regulatory@pagb.co.uk Introduction PAGB has

More information

Advertising Codes. Professional Code

Advertising Codes. Professional Code Medicines Advertising Codes Professional Code Including traditional herbal medicines CODES OF PRACTICE FOR ADVERTISING OVER-THE-COUNTER MEDICINES WHICH ARE SUBJECT TO A MARKETING AUTHORISATION OR TRADITIONAL

More information

Advertising Codes. Professional Code. Medicines. Including traditional herbal medicines

Advertising Codes. Professional Code. Medicines. Including traditional herbal medicines Medicines Advertising Codes Professional Code Including traditional herbal medicines CODES OF PRACTICE FOR ADVERTISING OVER-THE-COUNTER MEDICINES WHICH ARE SUBJECT TO A MARKETING AUTHORISATION OR TRADITIONAL

More information

How to prepare for third-party audits: Best practice for audit survival

How to prepare for third-party audits: Best practice for audit survival How to prepare for third-party audits: Best practice for audit survival Bessie Wang, MBA CHRL Director, Pharmacy Benefits Ontario Pharmacists Association Presenter disclosure Presenter s Name: Bessie Wang

More information

Our Story. An Australian-owned-and-operated largest Health Solution E-commerce Store

Our Story. An Australian-owned-and-operated largest Health Solution E-commerce Store Our Story An Australian-owned-and-operated largest Health Solution E-commerce Store OUR STORY Breakable is an Australian owned and operated e-commerce store, providing an end to end fast goods solutions

More information

Amcal Dispensary Solutions, making it easier Catalogue Issue 1

Amcal Dispensary Solutions, making it easier Catalogue Issue 1 Dispense@Amcal Amcal Dispensary Solutions, making it easier. 2018 Catalogue Issue 1 Brian Tomlin General Manager Retail (Amcal and Guardian) It s with great pleasure that I launch the first Dispense@Amcal

More information

New Mexico Retiree Health Care Authority Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

New Mexico Retiree Health Care Authority Prescription Drug Program Express Scripts Holding Company. All Rights Reserved. New Mexico Retiree Health Care Authority Prescription Drug Program 1 Who Is Express Scripts? Express Scripts is the largest Prescription Benefit Manager in the country with more than 100 million people

More information

News For Immediate Release

News For Immediate Release News For Immediate Release Contact: Gary Gatyas IMS Institute for Healthcare Informatics (610) 244-2600 ggatyas@us.imshealth.com IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly

More information

Taking Advantage of New Regulatory Flexibility

Taking Advantage of New Regulatory Flexibility MARKETING ISSUES Taking Advantage of New Regulatory Flexibility Michael Adelberg, Principal, FaegreBD Consulting Kelli Back, Attorney, Law Offices of Kelli Back Matt Feret, Chief Sales Officer, Medicare,

More information

CURRENT POLICY ON ACCESS TO MEDICINES AND HEALTH IN EUROPE. The role of Biosimilar Medicines

CURRENT POLICY ON ACCESS TO MEDICINES AND HEALTH IN EUROPE. The role of Biosimilar Medicines CURRENT POLICY ON ACCESS TO MEDICINES AND HEALTH IN EUROPE The role of Biosimilar Medicines Marc A. Mahl, MD MBA(INSEAD) President, Medicines for Europe Baltimore, 05 th September 2018 patients quality

More information

Get Ready... Get Set... Save!

Get Ready... Get Set... Save! Get Ready... Get Set... Save! InterNACHI members already protect your investment when you buy real estate. Now, we are helping our customers save money on everyday items just by getting and using the TopNACHI

More information

YOUR STORE BRAND. Private Label Merchandising & Marketing Best Practices

YOUR STORE BRAND. Private Label Merchandising & Marketing Best Practices YOUR STORE BRAND Private Label Merchandising & Marketing Best Practices Why Private Label? Private Label = Profit Builder Store Brands are more than TWICE as profitable as National Brands Store Brands

More information

Moving from R&D to Sales and Marketing: the business analytics experience of a statistician at Lilly

Moving from R&D to Sales and Marketing: the business analytics experience of a statistician at Lilly Moving from R&D to Sales and Marketing: the business analytics experience of a statistician at Lilly Todd Sanger, Ph.D. Research Fellow, Advanced Analytics Eli Lilly & Company Questions in Sales and Marketing

More information

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide

Romania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide Romania Raluca Vasilescu Cabinet M Oproiu Pharmaceutical Trademarks 2015/2016 A Global Guide Romania Cabinet M Oproiu Author Raluca Vasilescu Selection, clearance and registration In Romania, pharmaceutical

More information

Interchangeability: What is Next? Analysis of the concept & of the FDA Draft Guidance

Interchangeability: What is Next? Analysis of the concept & of the FDA Draft Guidance Interchangeability: What is Next? Analysis of the concept & of the FDA Draft Guidance Hillel Cohen, Executive Director of Scientific Affairs Leading on Biosimilars: The 2017 AAM Biosimilars Council Conference

More information

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin Coordinated Primary Options Service DVT Management Plan Management options using Dabigatran or Warfarin Name NHI DOB Ethnicity Gender Address Contact Information Mobile Home Treatment commenced date *CPO

More information

BIOSIMILAR AWARENESS INITIATIVE PROJECT MANAGEMENT PLAN

BIOSIMILAR AWARENESS INITIATIVE PROJECT MANAGEMENT PLAN BIOSIMILAR AWARENESS INITIATIVE PROJECT MANAGEMENT PLAN Date: June 2016 This document and its attachments are UNCLASSIFIED PRINCE2 Project Initiation Documentation TABLE OF CONTENTS 1 PROJECT DEFINITION...

More information

Partnering Virtual Pharmacies & Expert Recommendations

Partnering Virtual Pharmacies & Expert Recommendations Partnering Virtual Pharmacies & Expert Recommendations to Drive Powerful Consumer Health Marketing Tom Hartley GfK Health 1 Optimizing pharmacy selling strategies Introducing Simstore Dialogue GfK May

More information

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research

More information

Doctor of Pharmacy Course Descriptions

Doctor of Pharmacy Course Descriptions Doctor of Pharmacy Course Descriptions Required Courses Pharmacy Practicum II (7002) Second practicum with direct instruction by an experienced preceptor to increase the student's awareness of the pharmacist's

More information

Un Futuro Prometedor:

Un Futuro Prometedor: Un Futuro Prometedor: Profiling the Hispanic Shopper Devora Rogers Senior Director, Retail Marketing Insights About Inmar Manages more print and digital retail content than any other company globally Largest

More information

The future of biologics: reverse engineering for successful product supply

The future of biologics: reverse engineering for successful product supply The future of biologics: reverse engineering for successful product supply CORNELL STAMORAN VP, STRATEGY & CORPORATE DEV T. 03.10.11 Catalent s biologics presence Advanced GPEx cell line engineering technology

More information

Case Report. Food and Beverage Code 2.1 (a) - Misleading / deceptive Health and Safety Within prevailing Community Standards

Case Report. Food and Beverage Code 2.1 (a) - Misleading / deceptive Health and Safety Within prevailing Community Standards Case Report 1 Case Number 0237/16 2 Advertiser Health World Limited 3 Product Health Products 4 Type of Advertisement / media TV - Free to air 5 Date of Determination 08/06/2016 6 DETERMINATION Dismissed

More information

A. TRIAL IDENTIFICATION

A. TRIAL IDENTIFICATION PROTOCOL INFORMATION ON A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE CONDUCTED IN A THIRD COUNTRY (i.e. a country outside of the EEA) Note: To ensure consistency the numbering of this form is

More information

Derm Drugs: The Price is Too Darn High!

Derm Drugs: The Price is Too Darn High! Derm Drugs: The Price is Too Darn High! By Jacob Levitt, MD, FAAD Vice Chairman, Program Director, and Associate Professor The Mount Sinai Medical Center Department of Dermatology New York, NY 1 Disclosures

More information

How to treat more patients and make money in emerging markets

How to treat more patients and make money in emerging markets 1 How to treat more patients and make money in emerging markets AUTHOR Raja Shankar RShankar@imscg.com People buy innovative products in emerging markets. Millions of Brazilians, Russians, Indians, Chinese,

More information

MMCAP. Government Serving Government

MMCAP. Government Serving Government MMCAP Government Serving Government MMCAP Mission Minnesota Multistate Contracting Alliance for Pharmacy Ensure best value for pharmaceuticals and health care products and services to government facilities

More information

Donald Hackett President & CEO

Donald Hackett President & CEO Donald Hackett President & CEO Outline The Convergence of Four Major Forces Privacy vs Security What e-healthcare companies must do Four Forces Converging Reach Media Interactivity Healthcare Consumers

More information

Better Regulation and Medicines. Chris Horsey Head of Better Regulation Department of Health, England ASMI Conference, Sydney, 12 November 2009

Better Regulation and Medicines. Chris Horsey Head of Better Regulation Department of Health, England ASMI Conference, Sydney, 12 November 2009 Better Regulation and Medicines Chris Horsey Head of Better Regulation Department of Health, England ASMI Conference, Sydney, 12 November 2009 Contents Policy and regulatory context Legacy of medicines

More information

Online Marketing Budget & User Behavior For The Healthcare Industry. Visit Us Online : or Call Us At : (512)

Online Marketing Budget & User Behavior For The Healthcare Industry. Visit Us Online :  or Call Us At : (512) 2016 Online Marketing Budget & User Behavior For The Healthcare Industry Visit Us Online : www.theleverageway.com or Call Us At : (512) 561-4203 Table of Contents 01 02 03 05 09 12 14 Executive Summary

More information

WHY TRUE RX? Trust True Rx pharmacists consult one-on-one with clients to hold down prescription costs.

WHY TRUE RX? Trust True Rx pharmacists consult one-on-one with clients to hold down prescription costs. WHY TRUE RX? Mark Williams, RPh Nathan Gabhart, RPh Trust True pharmacists consult one-on-one with clients to hold down prescription costs. Integrity True clients pay the TRUE cost of the prescription,

More information

The Internet Pharmacy 46 th AESGP Annual Meeting Dubrovnik 2010

The Internet Pharmacy 46 th AESGP Annual Meeting Dubrovnik 2010 The Internet Pharmacy 46 th AESGP Annual Meeting Dubrovnik 2010 by James W. Dudley Tel. ++ 44 1562 747705 Fax ++ 44 1562 750275 e-mail information@james-dudley.co.uk Source: OTC Distribution in Europe

More information

Bi Regional Consultation on Good Governance

Bi Regional Consultation on Good Governance Pharmaceutical Services Ministry of Health Malaysia GGM PROGRAMME IN MALAYSIA WHO Collaborating Centre For Regulatory Control of Pharmaceuticals Bi Regional Consultation on Good Governance 9 th November

More information

Resume R O S A N A MA R I E L F E L I C E. Buenos Aires - Argentina. Medical doctor, Clinical Pharmacology and Gynecology and Obstetrics specialist.

Resume R O S A N A MA R I E L F E L I C E. Buenos Aires - Argentina. Medical doctor, Clinical Pharmacology and Gynecology and Obstetrics specialist. Resume R O S A N A MA R I E L F E L I C E Buenos Aires - Argentina Professional profile Medical doctor, Clinical Pharmacology and Gynecology and Obstetrics specialist. Heavily experienced in Pharmaceutical

More information

MassHealth Pharmacy Program: Strategies and Lessons

MassHealth Pharmacy Program: Strategies and Lessons MassHealth Pharmacy Program: Strategies and Lessons Prepared for Community Catalyst Massachusetts Health Policy Forum November 13, 2009 Cindy Parks Thomas Jeffrey Prottas Schneider Institute for Health

More information

The 2018 Therapeutic Goods Advertising Code & associated guidance

The 2018 Therapeutic Goods Advertising Code & associated guidance Complementary Medicines Australia submission to the Therapeutic Goods Administration Consultation: The 2018 Therapeutic Goods Advertising Code & associated guidance April 2018 To: Advertising Consultation

More information